http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2203674-C1
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a5ef89a82ef219f2acda6e0646b4b862 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-10 |
filingDate | 2001-10-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2003-05-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ea3182e37035b200f0cd127c32e85f61 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b56f89c7a9b7aebb49926429a3cab189 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c0a9c7b34c2518644578714898fcd85c |
publicationDate | 2003-05-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | RU-2203674-C1 |
titleOfInvention | Homeopathic preparation for treating myopia |
abstract | FIELD: medicine, homeopathy, ophthalmology. SUBSTANCE: the innovation deals with homeopathic preparations used in the field of ophthalmology in treating myopia of I, II and III degree. It is suggested to apply preparation containing Acidum phosphoricum, Cuprum metallicum, Gelsemium, Magnesia phosphorica taken in equal ratios at C6 dilution, moreover, this preparation is designed in the form of sugar granules. It has no side effects, contraindications for usage, it could be combined with other therapeutic methods and preparations and could be, also, applied in monotherapy. EFFECT: higher efficiency of therapy. 1 cl, 2 ex, 1 tbl |
priorityDate | 2001-10-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 21.